Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer
Crossref DOI link: https://doi.org/10.1007/s10549-014-3121-5
Published Online: 2014-09-09
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tanioka, M.
Sakai, K.
Sudo, T.
Sakuma, T.
Kajimoto, K.
Hirokaga, K.
Takao, S.
Negoro, S.
Minami, H.
Nakagawa, K.
Nishio, K.
Text and Data Mining valid from 2014-09-09